JOHNSON & JOHNSON

Companies supplying major manufacturers fail to meet promises to share land, joint BBC investigation finds.

We're making a few trades in the portfolio Friday, selling a less favored name to buy higher quality stocks.

The high grading of our portfolio continued Wednesday morning, with the moves made on American Eagle Outfitters and Johnson & Johnson.

After calling up a handful of names, we want to refresh a company already in our Bullpen, in addition to putting another one on it.

Free COVID-19 vaccinations will be available at three vaccine clinics at Ann Arbor YMCA’s downtown location, 400 W. Washington St., this week.

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

J&J announced in November that it would sheer off the consumer health business from its faster-growing medical devices and pharmaceutical portfolios.

Cross-contamination of coronavirus vaccines being made for Johnson & Johnson and AstraZeneca was discovered in March 2021. The company had more than $1.3 billion worth of contracts from the federal government and from Johnson & Johnson and AstraZeneca to make the vaccines. The hold tags indicated a potential quality problem with the vaccine in the containers, the House panel found. After discovery of cross-contamination, the Biden administration suspended the plant’s production of the Johnson & Johnson vaccine in April and permanently halted production of the AstraZeneca vaccine at the plant. But even after the restart in August, problems continued, according to the House report.

Federal regulators are limiting the use of Johnson & Johnson’s COVID-19 vaccine to cases where mRNA vaccines aren’t an option. An exception will be made if an adult elects to receive the J&J shot and would otherwise not receive a COVID-19 vaccine. After further review by the CDC’s advisory committee, and time for physicians to learn how to treat the condition, regulators allowed use of the Johnson & Johnson vaccine to resume. Among them, 393,366 residents received a Johnson & Johnson shot, including only 10,221 since Jan. 1. Spring surge pushes beyond metro Detroit: Michigan COVID data for Thursday, May 5Fire Watch issued for parts of Michigan with warm, dry weekend ahead

The suit seeks punitive damages, calls for a hospital, mental health and education programs, as well as a Tulsa Massacre Victims Compensation Fund.

These are the stocks posting the largest moves in midday trading.

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and stopped providing Covid-19 vaccine sales guidance due to a global supply surplus and demand uncertainty. J&J is now forecasting 2022 sales of $94.8 billion to $95.8 billion, about one billion dollars lower than the guidance provided in January. J&J reported first-quarter sales of $23.4 billion, slightly missing Wall Street expectations but growing 5% over the same quarter last year. The company's medical devices business grew by 5.9% to $6.97 billion in sales compared to the first quarter of 2021. "Looking ahead, I remain confident in the future of Johnson & Johnson as we continue advancing our portfolio and innovative pipeline."

Stock futures moved higher early Tuesday morning after stocks slipped during regular trading hours on Monday.

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.

An appeals court judge found that the company made misleading and potentially harmful statements in advertisements and instructional brochures.

A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.

Michigan is set to receive $776 million from three opioid distributors and an opioid manufacturer, as part of a $26 billion nationwide settlement for their role in the opioid epidemic. The money comes from pharmaceutical distributors Cardinal, McKesson and AmerisourceBergen as well as opioid manufacturer Johnson & Johnson. It’s one of the largest multi-state agreement in U.S. history, second only to the tobacco settlement of 1998. Nessel said the payout could top $1 billion once Purdue Pharma’s still-pending settlement money is added to the pot. RELATED STORIESNew vending machine at Ann Arbor library offers free kits to stop opioid overdosesOne of Michigan’s top payouts from national opioid lawsuits settlement could come to Washtenaw CountyGenesee County to receive nearly $16M from historic opioid settlement

A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers.

Three upcoming vaccine clinics at the Ann Arbor YMCA are free and open to the public.

Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo.

Johnson & Johnson's new CEO Joaquin Duato says in his first interview that AI in medicine will lead to innovations including real-time surgery decisions.

Monroe County will soon see some money from a roughly $26 billion national opioid settlement that was finalized last month.

Tatum Strieter-Byron is asking the federal government to compensate her for her mother Sandra Jacobs’ death in April of a confirmed complication of the Johnson & Johnson COVID-19 vaccine. It was established because COVID-19 vaccine manufacturers and others are granted liability protections through the Public Readiness Emergency Preparedness Act, enacted in 2005. In 2020, the U.S. Health and Human Services secretary invoked the act and declared COVID-19 a public health emergency, warranting Johnson & Johnson and others immunity from lawsuits. About 18.5 million Johnson & Johnson doses have been administered in the United States, making the side-effect rare. The CDC now recommends the Pfizer and Moderna vaccines over the Johnson & Johnson vaccine because of the risk of serious adverse events.

"It's not enough, but it's a good start," one lawyer said of settlement to fund local treatment and education efforts.

A federal judge has allowed a Johnson & Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company's baby powder.

The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis.

Analysis finds "unexpected levels" of human carcinogen coming from propellant that sprays product out of the can.

Moderna dropped more than 12%, the biggest decline in the S&P 500 as of Monday afternoon.

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

The only Johnson & Johnson facility making usable batches of the company's Covid vaccine has temporarily halted its production, The New York Times reported.

Money that will flow to Native American tribes as part of an opioid drug settlement with a major manufacturer and three distributors won't come quickly.

All federally recognized tribes in the U.S. will be able to participate in the settlements, even if they did not sue over opioids.

Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.

Landmark legal settlement offers "measure of justice" to Native American communities hit by opioid epidemic.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.

The Czech Republic has recorded a significant decline in people dying of COVID-19 despite facing a record number of infected in one month.

The U.S. Food and Drug Administration on Monday, Jan. 31, fully approved the Moderna COVID-19 vaccine. Updated analyses to determine the effectiveness of the Moderna vaccine included 14,287 vaccine recipients and 14,164 placebo recipients 18 and older who did not have evidence of coronavirus infection before receiving their first dose. The Moderna vaccine is the second most commonly administered vaccine in Michigan. Fewer than 400,000 people received the Johnson & Johnson and about 43,000 got the booster. The Pfizer and Moderna mRNA vaccines are preferred to the Johnson & Johnson vaccine, linked to deaths from a rare, but serious blood clotting disorder.

Denmark is scraping most pandemic restrictions as the country no longer considers COVID-19 to be “a socially critical disease.”.

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

The stocks making the biggest moves in premarket trading include 3M, Johnson & Johnson, General Electric and more.

Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings' estimates but missed on revenue. Revenue: $24.8 billion, vs. $25.29 billion expectedCFO Joseph Wolk told CNBC a strengthening dollar negatively impacted top line sales by $150 million to $200 million. Hospital staffing shortages caused by the omicron Covid variant also generated uncertainty in the company's medical devices business, particularly with elective procedures, Wolk said. J&J reported $93.77 billion in sales in 2021, a 13.6% increase over the prior year. J&J said it expects to generate $10.40 to $10.60 in earnings per share this year and $98.9 billion to $100.4 billion in revenue.

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.

The Wisconsin senator said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

Wall Street analysts say Johnson & Johnson's decision to spin off its consumer division is overall a smart business move but it could come with some risks.

The clinic will be held in Ballroom A of the EMU Student Center between 10 a.m. to 4 p.m.

Cahoots will be offering a walk-in COVID vaccine clinic on Thursday.

Two studies that have not yet been peer reviewed indicate increased protection against the infectious omicron variant.

Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & Johnson stock, each worth between $1,000 and $15,000.

More than half a dozen recalls have been issued this year as carcinogen is also found in sunscreens, foot deodorants.

Oregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.

South African President Cyril Ramaphosa has returned to work following a week of isolation after testing positive for COVID-19

These are the stocks posting the largest moves in midday trading.

Though reported Omicron cases have so far been mild, experts advise that every precaution should be taken to prevent infection.

Individuals unable or unwilling to receive an mRNA vaccine will continue to have access to the Johnson & Johnson vaccine, approved in February for American adults, the CDC reported. There is not an increased risk of the disorder after doses of the Pfizer and Moderna vaccines, according to the CDC. In April, the Johnson & Johnson vaccine brought about the death of a Michigan woman, 60-year-old Sandra Jacobs of Saline. Johnson & Johnson is the least commonly administered of the three vaccines. In April, when distribution of the Johnson & Johnson vaccine resumed after a pause to explore the reports of TTS, it was said to be 90% effective against hospitalization.

A federal vaccine advisory committee is now recommending the Pfizer and Moderna vaccines over the Johnson & Johnson vaccine, linked to rare but serious blood clotting disorder, according to the Associated Press. In April, the Johnson & Johnson vaccine brought about the death of a Michigan woman, 60-year-old Sandra Jacobs of Saline. RELATED: Michigan woman’s death caused by rare Johnson & Johnson COVID vaccine side effect, autopsy report saysJust five days earlier, federal health agencies temporarily paused the vaccine administration while they examined the vaccine and TTS. Federal heath authorities already have said that those receiving the Johnson & Johnson vaccine could get a Moderna or Pfizer booster shot. Early data indicated a dose of mRNA vaccine after the Johnson & Johnson vaccine would be better than a second dose of the Johnson & Johnson shot, providing a greater rise in antibodies.

The U.S. Centers for Disease Control and Prevention said on Thursday it had received reports of eight cases of myocarditis, a type of heart inflammation, in children aged 5-11 years who received Pfizer and BioNTech's COVID-19 vaccine.

The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine. Seventeen men developed TTS. A week later, the FDA and the CDC lifted the pause on J&J shots after the independent advisory panel said the benefits of the shots outweighed the risks. In October, the FDA and CDC authorized J&J boosters for all adults at least two months after receiving their initial J&J shot. People who received their primary vaccination with the J&J shot can also get boosted with the Pfizer or Moderna vaccines.

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

The European Union drugs regulator says people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.

Mississippi alleges the consumer products giant failed to warn users of "potentially lethal" health risks.

U-M officials issue guidance to school community ahead of holiday travel.

The Supreme Court has turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum powder products.

The U.N.-led initiative is now aiming for 800 million doses to be delivered by the end of the year, but that isn't assured.

Johnson said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

Since the coronavirus pandemic began, Dr. Frank McGeorge has been keeping viewers up-to-date and informed on all fronts.

Washington Attorney General Bob Ferguson has taken the state’s case against the nation’s three biggest drug distributors to trial.

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.

The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases.

The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

The federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland- based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated vaccine doses this spring.

Here we are tracking Michigan’s COVID-19 vaccine coverage.

Top drug manufacturers have won a round in a California lawsuit that blamed them for the opioid crisis and sought billions of dollars to cover the costs of dealing with it.

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

The Food and Drug Administration is enforcing new warnings on breast implants.

The boosters will be available at October drive-through clinics and ongoing walk-in clinics by the Washtenaw County Health Department.

Michiganders who are eligible to receive a COVID-19 vaccine booster dose are urged to do so now.

While vaccines have been overwhelmingly successful at protecting people from contracting the virus, in rare cases, there have been documented illnesses and even deaths.

Michiganders who are eligible to receive a COVID-19 vaccine booster dose from Johnson & Johnson or Moderna are urged to do so now.

Federal health officials say millions more Americans can get a COVID-19 booster and choose a different vaccine for that next shot.

Asian stock markets are higher after Wall Street rose for a fifth day on strong corporate earnings.

Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots this week.

The Food and Drug Administration is expected to announce this week people will be able to receive a COVID-19 vaccine booster shot with a vaccine from a different manufacturer than their original doses, according to reports in the New York Times, Washington Post and Wall Street Journal.

Sales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.

Michigan business groups are urging President Joe Biden to reconsider a plan to require most workers to get vaccinated or regularly tested for COVID-19 but say, if it is enacted, Gov. Gretchen Whitmer should ensure related state rules are no stricter.

The outside panel of experts voted unanimously in favor of offering booster doses of the Johnson & Johnson vaccine at least two months after the first dose.

Police departments that are requiring officers to be vaccinated against COVID-19 are running up against pockets of resistance across the U.S. Police unions and officers are pushing back by filing lawsuits to block the mandates.

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

The outside panel of experts voted unanimously in favor of offering Moderna boosters to specific groups of people, at least six months after their second dose.

The Food and Drug Administration’s (FDA) vaccine advisory panel is set to meet Thursday and Friday, Oct. 14-15, over Moderna and Johnson & Johnson booster shots.

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.

The Food and Drug Administration’s vaccine advisory panel is set to meet Thursday and Friday, Oct. 14-15, and we are getting our first look at the data the panel will be using to make its recommendation on booster shots for Moderna and Johnson & Johnson.

COVID-19 test kit maker Ellume is recalling some at-home tests after learning that they were reporting a higher-than-expected rate of false positive results.

Johnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine as the U.S. government moves toward shoring up protection in more vaccinated Americans.